Cargando…
Extracellular Vesicles Are More Potent Than Adipose Mesenchymal Stromal Cells to Exert an Anti-Fibrotic Effect in an In Vitro Model of Systemic Sclerosis
Systemic sclerosis (SSc) is a complex disorder resulting from dysregulated interactions between the three main pathophysiological axes: fibrosis, immune dysfunction, and vasculopathy, with no specific treatment available to date. Adipose tissue-derived mesenchymal stromal cells (ASCs) and their extr...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8269376/ https://www.ncbi.nlm.nih.gov/pubmed/34202139 http://dx.doi.org/10.3390/ijms22136837 |
_version_ | 1783720565630042112 |
---|---|
author | Rozier, Pauline Maumus, Marie Bony, Claire Maria, Alexandre Thibault Jacques Sabatier, Florence Jorgensen, Christian Guilpain, Philippe Noël, Danièle |
author_facet | Rozier, Pauline Maumus, Marie Bony, Claire Maria, Alexandre Thibault Jacques Sabatier, Florence Jorgensen, Christian Guilpain, Philippe Noël, Danièle |
author_sort | Rozier, Pauline |
collection | PubMed |
description | Systemic sclerosis (SSc) is a complex disorder resulting from dysregulated interactions between the three main pathophysiological axes: fibrosis, immune dysfunction, and vasculopathy, with no specific treatment available to date. Adipose tissue-derived mesenchymal stromal cells (ASCs) and their extracellular vesicles (EVs) have proved efficacy in pre-clinical murine models of SSc. However, their precise action mechanism is still not fully understood. Because of the lack of availability of fibroblasts isolated from SSc patients (SSc-Fb), our aim was to determine whether a TGFβ1-induced model of human myofibroblasts (Tβ-Fb) could reproduce the characteristics of SSc-Fb and be used to evaluate the anti-fibrotic function of ASCs and their EVs. We found out that Tβ-Fb displayed the main morphological and molecular features of SSc-Fb, including the enlarged hypertrophic morphology and expression of several markers associated with the myofibroblastic phenotype. Using this model, we showed that ASCs were able to regulate the expression of most myofibroblastic markers on Tβ-Fb and SSc-Fb, but only when pre-stimulated with TGFβ1. Of interest, ASC-derived EVs were more effective than parental cells for improving the myofibroblastic phenotype. In conclusion, we provided evidence that Tβ-Fb are a relevant model to mimic the main characteristics of SSc fibroblasts and investigate the mechanism of action of ASCs. We further reported that ASC-EVs are more effective than parental cells suggesting that the TGFβ1-induced pro-fibrotic environment may alter the function of ASCs. |
format | Online Article Text |
id | pubmed-8269376 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-82693762021-07-10 Extracellular Vesicles Are More Potent Than Adipose Mesenchymal Stromal Cells to Exert an Anti-Fibrotic Effect in an In Vitro Model of Systemic Sclerosis Rozier, Pauline Maumus, Marie Bony, Claire Maria, Alexandre Thibault Jacques Sabatier, Florence Jorgensen, Christian Guilpain, Philippe Noël, Danièle Int J Mol Sci Article Systemic sclerosis (SSc) is a complex disorder resulting from dysregulated interactions between the three main pathophysiological axes: fibrosis, immune dysfunction, and vasculopathy, with no specific treatment available to date. Adipose tissue-derived mesenchymal stromal cells (ASCs) and their extracellular vesicles (EVs) have proved efficacy in pre-clinical murine models of SSc. However, their precise action mechanism is still not fully understood. Because of the lack of availability of fibroblasts isolated from SSc patients (SSc-Fb), our aim was to determine whether a TGFβ1-induced model of human myofibroblasts (Tβ-Fb) could reproduce the characteristics of SSc-Fb and be used to evaluate the anti-fibrotic function of ASCs and their EVs. We found out that Tβ-Fb displayed the main morphological and molecular features of SSc-Fb, including the enlarged hypertrophic morphology and expression of several markers associated with the myofibroblastic phenotype. Using this model, we showed that ASCs were able to regulate the expression of most myofibroblastic markers on Tβ-Fb and SSc-Fb, but only when pre-stimulated with TGFβ1. Of interest, ASC-derived EVs were more effective than parental cells for improving the myofibroblastic phenotype. In conclusion, we provided evidence that Tβ-Fb are a relevant model to mimic the main characteristics of SSc fibroblasts and investigate the mechanism of action of ASCs. We further reported that ASC-EVs are more effective than parental cells suggesting that the TGFβ1-induced pro-fibrotic environment may alter the function of ASCs. MDPI 2021-06-25 /pmc/articles/PMC8269376/ /pubmed/34202139 http://dx.doi.org/10.3390/ijms22136837 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Rozier, Pauline Maumus, Marie Bony, Claire Maria, Alexandre Thibault Jacques Sabatier, Florence Jorgensen, Christian Guilpain, Philippe Noël, Danièle Extracellular Vesicles Are More Potent Than Adipose Mesenchymal Stromal Cells to Exert an Anti-Fibrotic Effect in an In Vitro Model of Systemic Sclerosis |
title | Extracellular Vesicles Are More Potent Than Adipose Mesenchymal Stromal Cells to Exert an Anti-Fibrotic Effect in an In Vitro Model of Systemic Sclerosis |
title_full | Extracellular Vesicles Are More Potent Than Adipose Mesenchymal Stromal Cells to Exert an Anti-Fibrotic Effect in an In Vitro Model of Systemic Sclerosis |
title_fullStr | Extracellular Vesicles Are More Potent Than Adipose Mesenchymal Stromal Cells to Exert an Anti-Fibrotic Effect in an In Vitro Model of Systemic Sclerosis |
title_full_unstemmed | Extracellular Vesicles Are More Potent Than Adipose Mesenchymal Stromal Cells to Exert an Anti-Fibrotic Effect in an In Vitro Model of Systemic Sclerosis |
title_short | Extracellular Vesicles Are More Potent Than Adipose Mesenchymal Stromal Cells to Exert an Anti-Fibrotic Effect in an In Vitro Model of Systemic Sclerosis |
title_sort | extracellular vesicles are more potent than adipose mesenchymal stromal cells to exert an anti-fibrotic effect in an in vitro model of systemic sclerosis |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8269376/ https://www.ncbi.nlm.nih.gov/pubmed/34202139 http://dx.doi.org/10.3390/ijms22136837 |
work_keys_str_mv | AT rozierpauline extracellularvesiclesaremorepotentthanadiposemesenchymalstromalcellstoexertanantifibroticeffectinaninvitromodelofsystemicsclerosis AT maumusmarie extracellularvesiclesaremorepotentthanadiposemesenchymalstromalcellstoexertanantifibroticeffectinaninvitromodelofsystemicsclerosis AT bonyclaire extracellularvesiclesaremorepotentthanadiposemesenchymalstromalcellstoexertanantifibroticeffectinaninvitromodelofsystemicsclerosis AT mariaalexandrethibaultjacques extracellularvesiclesaremorepotentthanadiposemesenchymalstromalcellstoexertanantifibroticeffectinaninvitromodelofsystemicsclerosis AT sabatierflorence extracellularvesiclesaremorepotentthanadiposemesenchymalstromalcellstoexertanantifibroticeffectinaninvitromodelofsystemicsclerosis AT jorgensenchristian extracellularvesiclesaremorepotentthanadiposemesenchymalstromalcellstoexertanantifibroticeffectinaninvitromodelofsystemicsclerosis AT guilpainphilippe extracellularvesiclesaremorepotentthanadiposemesenchymalstromalcellstoexertanantifibroticeffectinaninvitromodelofsystemicsclerosis AT noeldaniele extracellularvesiclesaremorepotentthanadiposemesenchymalstromalcellstoexertanantifibroticeffectinaninvitromodelofsystemicsclerosis |